Screening for early prostate cancer detection may reduce the rate of newly diagnosed metastatic disease. In a published study researchers evaluated the incidence of a men receiving a diagnosis of metastatic prostate cancer at their initial prostate cancer diagnosis using data extracted from the Surveillance, Epidemiology, and End Results (SEER) Program database. Their analysis was [...]
The American Urological Association (AUA)'s updated Prostate-Specific Antigen Best Practice Statement first at the annual meeting of the AUA in April, has been published in the November issue of the Journal of Urology. The statement includes the controversial guidance that the prostate-specific antigen (PSA) test should be offered to men starting at the age of 40 years — [...]
As we all have probably have heard Senator Christopher J. Dodd of Connecticut announced that he had prostate cancer. According to his announcement he had a biopsy as a result of a blood test. We can only assume that the test referred to was a PSA test. The announcement also indicated that the cancer was [...]
The following statement about the recent controversy regarding PSA testing was issued this morning by the thirteen organizations , including Malecare, listed at the bottom of the statement: A JOINT STATEMENT FROM AMERICA'S PROSTATE CANCER ADVOCACY, EDUCATION, AND SUPPORT ORGANIZATIONS Since 1993, when the PLCO trial was started, we have awaited the results of this [...]
To continue my attempt to share information about recurrent and advanced prostate cancer I have been providing stories of different people’s journeys through the world of prostate cancer. To add to Scott Goodwin’s story I am now going to occasionally publish a story that is a little different. Pradeep Raj who lives in India has [...]
